ADAGE CAPITAL PARTNERS GP, L.L.C. - Q4 2020 holdings

$45.9 Billion is the total value of ADAGE CAPITAL PARTNERS GP, L.L.C.'s 801 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 0.0% .

 Value Shares↓ Weighting
XENE  XENON PHARMACEUTICALS INC$37,681,000
+38.9%
2,450,0000.0%0.08%
+20.6%
ARDX  ARDELYX INC$32,350,000
+23.2%
5,000,0000.0%0.07%
+7.6%
ERES  EAST RES ACQUISITION CO$27,913,000
+4.3%
2,750,0000.0%0.06%
-9.0%
AGLE  AEGLEA BIOTHERAPEUTICS INC$23,547,000
+11.0%
2,992,0000.0%0.05%
-3.8%
CRHCU  COHN ROBBINS HOLDINGS CORPunit 08/11/2025$21,500,000
+6.5%
2,000,0000.0%0.05%
-7.8%
HZACU  HORIZON ACQUISITION CORPunit 99/99/9999$21,120,000
+1.5%
2,000,0000.0%0.05%
-11.5%
PRQR  PROQR THRAPEUTICS N V$19,110,000
-12.3%
4,550,0620.0%0.04%
-23.6%
 MARINUS PHARMACEUTICALS INC$17,843,000
-5.1%
1,462,5000.0%0.04%
-17.0%
ALUS  ALUSSA ENERGY ACQUISITION CO$18,108,000
+1.3%
1,800,0000.0%0.04%
-13.3%
PEAK  HEALTHPEAK PROPERTIES INC$17,644,000
+11.3%
583,6430.0%0.04%
-5.0%
GRTX  GALERA THERAPEUTICS INC$15,442,000
+13.2%
1,509,5000.0%0.03%0.0%
QURE  UNIQURE NV$12,646,000
-1.9%
350,0000.0%0.03%
-12.5%
FSDC  FS DEV CORP$11,000,000
-1.8%
1,000,0000.0%0.02%
-14.3%
CRWD  CROWDSTRIKE HLDGS INCcl a$10,591,000
+54.3%
50,0000.0%0.02%
+35.3%
HSAQ  HEALTH SCIENCES ACQ CORP 2$10,248,000
+16.5%
800,0000.0%0.02%0.0%
ORTX  ORCHARD THERAPEUTICS PLCads$8,640,000
+5.1%
2,000,0000.0%0.02%
-9.5%
AUPH  AURINIA PHARMACEUTICALS INC$8,618,000
-6.1%
623,1100.0%0.02%
-17.4%
CBAY  CYMABAY THERAPEUTICS INC$8,323,000
-20.7%
1,450,0000.0%0.02%
-30.8%
KIN  KINDRED BIOSCIENCES INC$7,219,000
+0.5%
1,675,0000.0%0.02%
-11.1%
BCTG  BCTG ACQUISITION CORP$6,864,000
+10.4%
600,0000.0%0.02%
-6.2%
RCUS  ARCUS BIOSCIENCES INC$6,490,000
+51.5%
250,0000.0%0.01%
+27.3%
OTIC  OTONOMY INC$6,635,000
+59.8%
1,025,5000.0%0.01%
+40.0%
TIG  TREAN INS GROUP INC$5,240,000
-14.1%
400,0000.0%0.01%
-26.7%
FARM  FARMER BROS CO$4,061,000
+5.6%
869,6990.0%0.01%
-10.0%
CFRX  CONTRAFECT CORP$3,283,000
-4.3%
650,0000.0%0.01%
-22.2%
FI  FRANKS INTL N V$2,414,000
+77.9%
880,8460.0%0.01%
+66.7%
NLY  ANNALY CAPITAL MANAGEMENT IN$1,690,000
+18.7%
200,0000.0%0.00%0.0%
OII  OCEANEERING INTL INC$1,193,000
+125.9%
150,0000.0%0.00%
+200.0%
 CHENIERE ENERGY INCnote 4.250% 3/1$1,174,000
+8.1%
1,500,0000.0%0.00%0.0%
ERESW  EAST RES ACQUISITION CO*w exp 07/01/202$1,568,000
+78.2%
1,375,0000.0%0.00%
+50.0%
CUB  CUBIC CORP$871,000
+6.7%
14,0360.0%0.00%0.0%
ALUSWS  ALUSSA ENERGY ACQUISITION CO*w exp 10/31/202$1,107,000
+89.2%
900,0000.0%0.00%
+100.0%
PANAWS  PANACEA ACQUISITION CORP*w exp 07/07/202$853,000
+36.0%
266,6660.0%0.00%0.0%
ARNC  ARCONIC CORPORATION$1,118,000
+56.6%
37,5000.0%0.00%0.0%
CMTL  COMTECH TELECOMMUNICATIONS C$383,000
+47.9%
18,4990.0%0.00%0.0%
MOGA  MOOG INCcl a$599,000
+24.8%
7,5530.0%0.00%0.0%
SNDL  SUNDIAL GROWERS INC$426,000
+96.3%
900,0000.0%0.00%0.0%
ZSAN  ZOSANO PHARMA CORP$527,000
-67.5%
1,000,0000.0%0.00%
-75.0%
SVRA  SAVARA INC$460,000
+5.5%
400,0000.0%0.00%0.0%
BAK  BRASKEM S Asp adr pfd a$135,000
+20.5%
14,9400.0%0.00%
SPKE  SPARK ENERGY INC$129,000
+15.2%
13,4740.0%0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
APPLE INC43Q3 20236.0%
MICROSOFT CORP43Q3 20235.5%
AMAZON COM INC43Q3 20234.0%
BERKSHIRE HATHAWAY INC DEL43Q3 20231.3%
JPMORGAN CHASE & CO43Q3 20231.3%
EXXON MOBIL CORP43Q3 20231.6%
JOHNSON & JOHNSON43Q3 20231.2%
PROCTER & GAMBLE CO43Q3 20231.0%
WELLS FARGO CO NEW43Q3 20231.6%
UNITEDHEALTH GROUP INC43Q3 20231.2%

View ADAGE CAPITAL PARTNERS GP, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
ADAGE CAPITAL PARTNERS GP, L.L.C. Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CymaBay Therapeutics, Inc.September 11, 20233,685,6253.8%
Verastem, Inc.August 31, 20231,300,0005.2%
Molecular Templates, Inc.July 18, 20234,391,4895.4%
ABEONA THERAPEUTICS INC.July 06, 20233,249,99415.3%
Praxis Precision Medicines, Inc.June 30, 20237,930,6386.2%
REATA PHARMACEUTICALS INCJune 26, 20231,730,8415.2%
Provention Bio, Inc.February 21, 20235,398,8256.0%
ADAMS NATURAL RESOURCES FUND, INC.February 09, 20231,308,7915.4%
Akili, Inc.Sold outFebruary 09, 202300.0%
Ambrx Biopharma Inc.February 09, 20237,191,0372.7%

View ADAGE CAPITAL PARTNERS GP, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
SC 13G/A2024-04-11
SC 13G2024-02-26
SC 13G2024-02-26
SC 13G2024-02-23
13F-HR2024-02-14
SC 13G2024-02-12
SC 13G/A2024-02-07
SC 13G/A2024-02-07
SC 13G/A2024-02-07

View ADAGE CAPITAL PARTNERS GP, L.L.C.'s complete filings history.

Compare quarters

Export ADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings